The number of evaluable patients that will be needed depends on the number of times the dose is escalated or possibly de-escalated. If the escalation continues up through Dose Level IV, 15 evaluable patients will be required. If the dose is de-escalated after Dose Level II, then 10 evaluable patients will be required.